Home ›
Trademark Categories ›
Pharmaceuticals ›
2007 ›
CR ›
CRESLECT
Trademark search for:
CRESLECT
No active United States Patent and Trademark Office (USPTO) registrations found, based on publicly available USPTO trademark records.
Trademark records may change over time.
For the most up-to-date trademark status, domain availability,
and social handle checks, run a live search.
Check latest trademark, domains & social handles
Live search · Most up-to-date results
USPTO Filing History
Key events recorded for this trademark application
2007-02-08 — Application filed
2007-02-13 — Application filed
2007-03-29 — Assigned to examiner
2007-03-30 — Final disposition recorded
2007-03-30 — Final disposition recorded
2007-06-12 — Teas/email correspondence entered
2007-06-12 — Office action issued
2007-06-12 — Correspondence received in law office
2007-06-12 — Assigned to examiner
2007-06-14 — Approved for pub - principal register
2007-07-23 — Assigned to lie
2007-07-23 — Law office publication review completed
2007-08-08 — Notice of publication
2007-08-28 — Published for opposition
2007-11-20 — Noa mailed - sou required from applicant
2008-05-20 — Sou teas extension received
2008-05-20 — Sou extension 1 filed
2008-05-29 — Sou extension 1 granted
2008-09-26 — Sou teas extension received
2008-09-26 — Sou extension 2 filed
2008-09-29 — Case assigned to intent to use paralegal
2008-09-29 — Sou extension 2 granted
2009-04-16 — Sou teas extension received
2009-04-16 — Sou extension 3 filed
2009-04-22 — Sou extension 3 granted
2009-12-21 — Application abandoned
2009-12-21 — Application abandoned
2009-12-21 — Final status recorded
Owner Information
Amgen Inc.
Thousand Oaks , CA
Amgen Inc.
Thousand Oaks , CA
Correspondent
Mark I. Feldman, Christina L. Martini DLA PIPER US LLP P.O. Box 64807 Chicago, IL 60664-0807 UNITED STATES
Filing Details
Filing Date:
2007-02-08
Status Date:
2009-12-21
Disclaimer: This page is informational only and does not constitute legal advice.
Trademark availability depends on jurisdiction, usage, and legal interpretation.